This article will summarize the key results presented at ASH 2018 in the field of essential thrombocytopenia, polycythemia vera, myelofibrosis and rare myeproliferative neoplasms. In addition to this several interesting abstracts in the field of chronic myeloid leukemia are addressed (a more complete overview of CML highlights is given in another article in this BJH special).
(BELG J HEMATOL 2019;10(1):49–56)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
